Pediatric Oncology Prof. Dr. Nur Olgun
✓ Medically verified profileProf. Dr. Nur Olgun
✓ Medically verified profile
Quick answer
Prof. Dr. Nur Olgun is a pediatric oncologist at Acıbadem İzmir Kent Hospital, where she treats children with cancer in the Pediatric Oncology Unit.
Her areas of clinical interest include lymphoma, rare tumors, childhood brain tumors, and Wilms tumor, supported by a long academic career in pediatric oncology.
About Prof. Dr. Nur Olgun
Prof. Dr. Nur Olgun is a pediatric oncologist at İzmir Kent Hospital, providing care for children with lymphoma, rare tumors, brain tumors, and Wilms tumor. Her clinical focus is centered on the evaluation and treatment of childhood cancers.
She graduated from Ege University Faculty of Medicine in 1979 and completed further training in pediatrics, pediatric hematology and oncology, and oncology at Dokuz Eylül University. Her academic career at Dokuz Eylül University included faculty membership, leadership of the Oncology Institute, and service as Dean of the Faculty of Medicine.
International patients can expect consultation with an experienced pediatric oncology specialist who has worked in academic oncology and participates in national and international pediatric oncology professional organizations. Care discussions are focused on the child’s diagnosis and treatment needs.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 1998Dokuz Eylül University Faculty of Medicine Çocuk Hematolojisi ve Onkolojisi
- 1995Dokuz Eylül University, Onkoloji Institute, Professor Doktor
- 1989Dokuz Eylül University, Onkoloji Institute, Associate Professor Doktor
- 1984Dokuz Eylül University Faculty of Medicine Çocuk Sağlığı ve Hastalıkları
- 1979Ege University Faculty of Medicine
Professional Experience
- 2025Acıbadem Healthcare Services
- 2025Dokuz Eylül University, Onkoloji Institute, Emeklilik
- 2022–2024Dokuz Eylül University, Faculty of Medicine , Dekan
- 2012–2024Dokuz Eylül University, Onkoloji Institute, Enstitü Müdürü
- 1992–2025Dokuz Eylül University, Onkoloji Institute, Faculty Member , Enstitü Müdürü
- 1985–1992Dokuz Eylül University, Faculty of Medicine , Çocuk Sağlığı ve Hastalıkları, Çocuk Onkolojisi Bilim Dalı, Faculty Member
Professional Memberships
- Türk Tabibler Birliği
- International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN)
- The Pediatric Oncology East and Mediterranean (POEM) Group
- Türk Pediatrik Onkoloji Grubu (TPOG) Association
- Türk Kanser Araştırma ve Savaş Vakfı
- International Society of Paediatric Oncology (SIOP)
- Türk Kanser Araştırma ve Savaş Kurumu Association, İzmir Şubesi
Selected Publications
- Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes J Clin Med. 2025 Jan 31;14(3):934 Olgun N, Arayici ME, Kizmazoglu D, Cecen RE.
- Investigation of YAP-1, OTX-2, and nestin protein expressions in neuroblastoma: a preliminary study. Ann Clin Transl Neurol. 2024 Aug;11(8):2153-2165. Kum Özşengezer S, Altun ZS, Sanlav G, Baran B, Kızmazoğlu D, Aktaş S, Keskinoğlu P, Olgun N.
- Low Expression of CASP8 Could be a Prognostic Biomarker in Neuroblastoma Patients. J Child Neurol. 2024 Oct;39(11-12):386-394. Altun Z, Ceyhan M, Yuan H, Kizmazoglu D, Aktas S, Olgun N.
- Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma Gene. 2023 Apr 15;860:147233. Altun Z, Yuan H, Baran B, Aktaş S, Sönmez EE, Küçük C, Olgun N.
- The association between birth weight and the risk of neuroblastoma: a meta-analysis of observational studies involving 4,361,141 participants. Am J Cancer Res. 2023 Sep 15;13(9):3854-3863. Olgun HN, Arayici ME, Cecen RE, Basbinar Y, Ellidokuz H.
- Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patient Clin Med Insights Oncol. 2023 Sep 19;17:11795549231199926. Baran B, Sanlav G, Kizmazoglu D, Kum Ozsengezer S, Aktas S, Altun Z, Olgun N.
- Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies Front Biosci (Landmark Ed). 2023 Aug 17;28(8):171. Aktas T, Kizmazoglu D, Aktas S, Erol A, Serinan E, Gokbayrak O, Ozdemir SM, Altun Z, Ozer E, Cecen E, Ince D, Olgun N.
- Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience. Front Oncol. 2022 Dec 23;12:1041443 Olgun N, Cecen E, Ince D, Kizmazoglu D, Baysal B, Onal A, Ozdogan O, Guleryuz H, Cetingoz R, Demiral A, Olguner M, Celik A, Kamer S, Ozer E, Altun Z,
- Treatment of high-risk neuroblastoma: National protocol results of the Turkish Pediatric Oncology Group. J Cancer Res Ther. 2017 Apr-Jun;13(2):284-290. Aksoylar S, Varan A, Vergin C, Hazar V, Akici F, Dagdemir A, Buyukavci M, Kebudi R, Kurucu N, Sevinir B, Unal E, Vural S, Guler E, Apak H, Oniz H, Kar
- Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol. Pediatr Hematol Oncol. 2003 Apr-May;20(3):211-8. Olgun N, Kansoy S, Aksoylar S, Cetingul N, Vergin C, Oniz H, Sarialioglu F, Kantar M, Uysal K, Tuncyurek M, Kargi A, Aktas S, Bayol U, Karaca I, Arika
Frequently Asked Questions
What is Dr. Nur Olgun's specialty?
Which hospital does Dr. Nur Olgun practise at?
What languages can I use when consulting Dr. Nur Olgun?
How can I book an appointment with Dr. Nur Olgun?
Is an online video consultation available with Dr. Nur Olgun?
How many years of experience does Dr. Nur Olgun have?
Can international patients arrange treatment with Dr. Nur Olgun?
How do I get a second opinion involving Dr. Nur Olgun?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Prof. Dr. Nur Olgun
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Hospitals
Treatments Performed
What patients say about Prof. Dr. Nur Olgun
★★★★★From 2,400+ verified patient reviews“My anaesthesia care exceeded every expectation I had. Dr. Olguner explained every step clearly and never rushed me. I am deeply grateful for everything.”
“We brought our child in for cancer treatment and the care was wonderful. Prof. Dr. Olgun answered all our worried questions without making us feel silly. The facilities were spotless and modern.”